Susquehanna International Group’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,659
Closed -$35.3K 14130
2025
Q2
$35.3K Buy
6,659
+1,247
+23% +$6.71K ﹤0.01% 12207
2025
Q1
$23.9K Buy
+5,412
New +$35K ﹤0.01% 12070
2024
Q4
Sell
-2,816
Closed -$40.8K 13483
2024
Q3
$40.8K Buy
2,816
+831
+42% +$37.4K ﹤0.01% 11451
2024
Q2
$145K Buy
+1,985
New +$152K ﹤0.01% 10724
2024
Q1
Sell
-3,373
Closed -$247K 13625
2023
Q4
$247K Buy
3,373
+2,117
+169% +$87K ﹤0.01% 10242
2023
Q3
$48.8K Sell
1,256
-3,877
-76% -$197K ﹤0.01% 11318
2023
Q2
$296K Sell
5,133
-8,484
-62% -$515K ﹤0.01% 9460
2023
Q1
$885K Buy
13,617
+9,088
+201% +$550K ﹤0.01% 7131
2022
Q4
$125K Buy
4,529
+1,029
+29% +$27.5K ﹤0.01% 10729
2022
Q3
$102K Buy
3,500
+2,039
+140% +$69.9K ﹤0.01% 11693
2022
Q2
$28K Buy
+1,461
New +$73.4K ﹤0.01% 12255
2021
Q4
Sell
-5,628
Closed -$703K 14233
2021
Q3
$703K Buy
5,628
+4,410
+362% +$494K ﹤0.01% 8494
2021
Q2
$138K Sell
1,218
-62
-5% -$7.51K ﹤0.01% 11901
2021
Q1
$194K Buy
+1,280
New +$177K ﹤0.01% 11451

Other funds holding VRCA